Thursday, July 28, 2016

UPDATE 3-Sales of flagship drug Revlimid drive Celgene profit; forecast raised

NEW YORK, July 28 (Reuters) - Celgene Corp raised

its 2016 profit forecast and exceeded expectations for

second-quarter earnings on Thursday on the strength of its

flagship multiple myeloma drug...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)